Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02217475 · ClinicalTrials.gov registry record · Phase 2

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

A Phase 2 study of Nonalcoholic Steatohepatitis, sponsored by Tobira Therapeutics.

Completed
Registry status
Phase 2
Development phase
289
Enrollment target
20
Study locations

NCT02217475 is a Phase 2 study of Nonalcoholic Steatohepatitis that has completed, run by Tobira Therapeutics. The registered enrollment target is 289 participants, below the 1,013-participant average among 17 other Nonalcoholic Steatohepatitis trials with a reported enrollment target (71% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02217475, a Phase 2 study of Nonalcoholic Steatohepatitis, has completed, sponsored by Tobira Therapeutics.

COMPLETED
Registry status
Phase 2
Development phase
289 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine whether cenicriviroc is effective and safe in the treatment of nonalcoholic steatohepatitis (NASH) in adult participants with liver fibrosis.

Conditions Studied

Nonalcoholic Steatohepatitis

Interventions

  • DRUG Placebo
  • DRUG Cenicriviroc

Study Locations (20)

California

  • - Rialto
  • - San Diego
  • - San Diego
  • - San Francisco

Maryland

  • - Baltimore
  • - Baltimore
  • - Chevy Chase
  • - Lutherville

Arizona

  • - Phoenix
  • - Tucson

Florida

  • - Miami
  • - Tampa

Massachusetts

  • - Boston
  • - Worcester

Alabama

  • - Dothan

Colorado

  • - Littleton

Illinois

  • - Chicago

Trial Details

FieldValue
Enrollment Target 289 participants
Start Date 2014-09-18
Est. Completion 2017-06-22
Phase Phase 2

Sponsor

Tobira Therapeutics

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02217475

The ClinicalTrials.gov registry entry for NCT02217475 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,013-participant average among 17 other Nonalcoholic Steatohepatitis trials with a reported enrollment target (71% lower). The listed sponsor is Tobira Therapeutics, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nonalcoholic Steatohepatitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02217475 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Maryland, Arizona.

Frequently Asked Questions

What is clinical trial NCT02217475 about?

NCT02217475 is a clinical study titled "Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis". The purpose of this study is to determine whether cenicriviroc is effective and safe in the treatment of nonalcoholic steatohepatitis (NASH) in adult participants with liver fibrosis.

What is the current status of trial NCT02217475?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 289 participants. The study started on 2014-09-18. Estimated completion is 2017-06-22.

What conditions does trial NCT02217475 study?

This clinical trial studies the following conditions: Nonalcoholic Steatohepatitis.

What interventions are being tested in trial NCT02217475?

The interventions under investigation include: Placebo (DRUG), Cenicriviroc (DRUG).

Who is sponsoring clinical trial NCT02217475?

This trial is sponsored by Tobira Therapeutics, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02217475 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Nonalcoholic Steatohepatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Nonalcoholic Steatohepatitis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.